Heidrun Engler
Impact in
- Biotechnology top 5%
- Cancer Research and Treatments
- Genetics top 5%
- Virus-based gene therapy research
Papers in
- Co-authors
- Todd Machemer (8 shared papers)Istvan Szelenyi (3 shared papers)Erlinda Quijano (5 shared papers)Shu-Fen Wen (5 shared papers)Daniel C. Maneval (7 shared papers)Thomas Schluep (3 shared papers)Robert Connor (4 shared papers)Aijie Liu (1 shared paper)
- Journals
- Molecular Therapy (3 papers)Urology (2 papers)Journal of Clinical Oncology (1 paper)The Journal of Urology (1 paper)Journal of Medicinal Chemistry (1 paper)
- Partner nations
- United StatesGermanyJapan
In The Last Decade
Heidrun Engler
18 papers receiving 842 citations
Peers
Comparison fields: 5 of 90
- Biotechnology 147
- Genetics 350
- Urology 53
- Molecular Biology 468
- Oncology 173
Countries citing papers authored by Heidrun Engler
This map shows the geographic impact of Heidrun Engler's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Heidrun Engler with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Heidrun Engler more than expected).
Fields of papers citing papers by Heidrun Engler
This network shows the impact of papers produced by Heidrun Engler. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Heidrun Engler. The network helps show where Heidrun Engler may publish in the future.
Co-authors
The 25 scholars most cited alongside Heidrun Engler, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2004 | 241 | |
| 2 | 2001 | 113 | |
| 3 | 2002 | 105 | |
| 4 | 2004 | 76 | |
| 5 | 2002 | 57 | |
| 6 | 1984 | 48 | |
| 7 | 2004 | 44 | |
| 8 | 1983 | 44 | |
| 9 | 1999 | 41 | |
| 10 | 2005 | 33 | |
| 11 | 1991 | 26 | |
| 12 | Pharmacologic indicators of antitumor efficacy for oncolytic virotherapy. | 2003 | 20 |
| 13 | 2005 | 13 | |
| 14 | 2003 | 10 | |
| 15 | 1987 | 9 | |
| 16 | Cardiohistaminergics - new developments in histamine H_2-agonists | 1990 | 5 |
| 17 | 1999 | 1 | |
| 18 | 1,4-Dihydropyridinderivate, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel | 1986 | 1 |
About Heidrun Engler
Heidrun Engler is a scholar working on Genetics, Surgery, Molecular Biology, Oncology and Biotechnology, having authored 18 papers that have together received 887 indexed citations. Recurring topics across this work include Virus-based gene therapy research (11 papers), Cancer Research and Treatments (5 papers), Bladder and Urothelial Cancer Treatments (3 papers), CAR-T cell therapy research (3 papers), RNA Interference and Gene Delivery (3 papers), Renal and related cancers (2 papers), Viral gastroenteritis research and epidemiology (2 papers) and Drug Transport and Resistance Mechanisms (2 papers). The work is most often cited by research in Biotechnology (147 citations), Genetics (350 citations), Urology (53 citations), Molecular Biology (468 citations) and Oncology (173 citations). Heidrun Engler has collaborated with scholars based in United States, Germany and Japan. Frequent co-authors include Todd Machemer, Istvan Szelenyi, Erlinda Quijano, Shu-Fen Wen, Daniel C. Maneval, Thomas Schluep, Robert Connor, Aijie Liu, Jeremy D. Heidel and Mark E. Davis. Their work appears in journals such as Molecular Therapy, Urology, Journal of Clinical Oncology, The Journal of Urology and Journal of Medicinal Chemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.